Clinical Trial Update: Artificial Intelligence-Enhanced Management for Coronary Heart Disease (AIM-CHD) : Impact on Cholesterol and Other CHD Risk Factors [NA]

View source ↗

Summary

This document reports completion of the AIM-CHD trial evaluating AI-enhanced management for coronary heart disease and its impact on cholesterol and CHD risk fa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Secondary Prevention of Coronary Heart Disease | NA | Status: COMPLETED